"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 8 | 3 | 11 |
| 1996 | 8 | 0 | 8 |
| 1997 | 3 | 3 | 6 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 2 | 5 |
| 2000 | 7 | 3 | 10 |
| 2001 | 3 | 5 | 8 |
| 2002 | 9 | 4 | 13 |
| 2003 | 8 | 1 | 9 |
| 2004 | 10 | 6 | 16 |
| 2005 | 15 | 8 | 23 |
| 2006 | 15 | 6 | 21 |
| 2007 | 17 | 7 | 24 |
| 2008 | 16 | 11 | 27 |
| 2009 | 25 | 13 | 38 |
| 2010 | 20 | 11 | 31 |
| 2011 | 25 | 8 | 33 |
| 2012 | 23 | 13 | 36 |
| 2013 | 24 | 13 | 37 |
| 2014 | 31 | 17 | 48 |
| 2015 | 32 | 13 | 45 |
| 2016 | 28 | 7 | 35 |
| 2017 | 25 | 18 | 43 |
| 2018 | 24 | 13 | 37 |
| 2019 | 25 | 14 | 39 |
| 2020 | 20 | 16 | 36 |
| 2021 | 16 | 18 | 34 |
| 2022 | 2 | 31 | 33 |
| 2023 | 5 | 20 | 25 |
| 2024 | 14 | 11 | 25 |
| 2025 | 8 | 2 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic ß-cell function in obese male mice. Nat Commun. 2025 May 21; 16(1):4714.
-
Grandmaternal perinatal serum polychlorinated biphenyls and prevalence of obesity in adult daughters and granddaughters. Obesity (Silver Spring). 2025 Jun; 33(6):1165-1175.
-
12-Lipoxygenase Inhibition Improves Glycemia and Obesity-associated Inflammation in Male Human Gene Replacement Mice. Endocrinology. 2025 Apr 22; 166(6).
-
Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity. JAMA Health Forum. 2025 Apr 04; 6(4):e250905.
-
Comparison of Lean, Obese, and Weight-Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T-cell Populations. Cancer Res. 2025 Apr 03; 85(7):1219-1235.
-
Missense variants in FRS3 affect body mass index in populations of diverse ancestries. Nat Commun. 2025 Mar 25; 16(1):2694.
-
Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue. Mol Metab. 2025 May; 95:102126.
-
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. JAMA Health Forum. 2025 Mar 07; 6(3):e245586.
-
Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers. 2025 Mar 06; 11(1):14.
-
Exploring pathways between internalized weight bias, eating disorder psychopathology, and weight loss expectations in treatment-seeking adults with binge eating and obesity. Eat Weight Disord. 2025 Feb 21; 30(1):17.